Brown Rudnick advised Aerovate Therapeutics Inc. on the deal. Aerovate Therapeutics, Inc. (Nasdaq: AVTE), a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve...
This content is for Standard 1 Year members only. LoginJoin Now